Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RenoFive
- Development stage
- Unknown
- Lead developer
- TNF Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
**RenoFive** is a Hughes-developed **small-molecule nutraceutical ingredient** in **preclinical R&D** that is described as a **phosphorylated polyphenol** and a **ws-resveratrol precursor** derived from **pomelo extract**. It appears to be part of Hughes Biotechnology's RenoSorb postbiotic biotransformation platform, which is intended to improve the bioavailability of naturally occurring polyphenols through phosphorylation and related processing. No specific molecular target, clinical indication, dosage form, or human clinical development program has been disclosed; based on the available company pipeline information, RenoFive is best characterized as an early-stage resveratrol-related nutraceutical ingredient rather than a conventional pharmaceutical drug candidate.
- Brand names
- RenoFive
- Other names
- RenoFive-Hughes-small moleculeRenoFive-Hughes-small molecule phosphorylated polyphenol nutraceutical ingredientRenoFive-HughesRenoFive\u2122phosphorylated resveratrol precursorws-resveratrol precursor
Beyond the preview
Go deeper on RenoFive.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RenoFive.